New Daily Diabetes and Weight Loss Pill Launches in UK: Oral Alternative to Injections
The UK has become the first European country to approve the oral weight loss drug Orforglipron (brand name Foundayo). This once-daily tablet, developed by Eli Lilly, is suitable for people with BMI ≥30 or overweight individuals with weight-related conditions, and can also improve blood sugar control in type 2 diabetes patients, offering a new option for those who cannot use injections.